Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ophthotech nets $155.5mm through its IPO

Executive Summary

Ophthotech Corp. (focused on back-of-the-eye diseases) netted $155.5mm through its initial public offering of 7.6mm shares at $22, well above the latest prediction of $19-20 apiece. (Last month the company announced it planned to sell 5.7mm shares between $16-19.) Two of Ophthotech’s existing principal shareholders bought a total of 683k shares.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies